Patents by Inventor Scott R. Hambaugh

Scott R. Hambaugh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Tyrosine kinase inhibitors
    Patent number: 7262199
    Abstract: The present invention relates to compounds which inhibit, regulate and/or modulate tyrosine kinase signal transduction, compositions which contain these compounds, and methods of using them to treat tyrosine kinase-dependent diseases and conditions, such as angiogenesis, cancer, tumor growth, atherosclerosis, age related macular degeneration, diabetic retinopathy, macular edema, retinal ischemia, inflammatory diseases, and the like in mammals.
    Type: Grant
    Filed: December 5, 2003
    Date of Patent: August 28, 2007
    Assignee: Merck & Co., Inc.
    Inventors: Mark E. Fraley, Scott R. Hambaugh, Robert S. Rubino, Randall W. Hungate
  • Tyrosine kinase inhibitors
    Patent number: 6479512
    Abstract: The present invention relates to compounds which inhibit, regulate and/or modulate tyrosine kinase signal transduction, compositions which contain these compounds, and methods of using them to treat tyrosine kinase-dependent diseases and conditions, such as angiogenesis, cancer, tumor growth, atherosclerosis, age related macular degeneration, diabetic retinopathy, inflammatory diseases, and the like in mammals.
    Type: Grant
    Filed: October 17, 2000
    Date of Patent: November 12, 2002
    Assignee: Merck & Co., Inc.
    Inventors: Mark E. Fraley, Scott R. Hambaugh, Randall W. Hungate